???global.info.a_carregar???
Helena Cortez-Pinto.
Identification

Personal identification

Full name
Helena Cortez-Pinto

Citation names

  • Cortez-Pinto, Helena
  • Pinto, Helena C

Author identifiers

Ciência ID
A01C-0511-C986
ORCID iD
0000-0002-8537-8744
Education
Degree Classification
2000
Concluded
 Medicina (Doutoramento)
Major in Medicina
Universidade de Lisboa Faculdade de Medicina, Portugal
 20
1981
Concluded
 Medicina (Licenciatura)
Universidade de Lisboa Faculdade de Medicina, Portugal
 17
Affiliation

Teaching in Higher Education

Category
Host institution 		Employer
2016/12 - Current Full Professor (University Teacher) Universidade de Lisboa Faculdade de Medicina, Portugal

Other Careers

Category
Host institution 		Employer
2011 - Current Assistente graduado sénior (Médica) Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
Projects

Contract

Designation Funders
2017 - Current Litmus - Liver Investigation: Testing Marker Utility in Steatohepatitis
777377
Principal investigator
Universidade de Lisboa Faculdade de Medicina, Portugal
Ongoing
2022/01/01 - 2024/12/31 TRANSLATING RIPK3 SIGNALLING INTO APPLICATION IN METABOLIC LIVER DISEASE
PTDC/MED-FAR/3492/2021
Universidade de Lisboa Instituto de Investigação do Medicamento, Portugal

Universidade de Lisboa Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Ongoing
2018/06/01 - 2022/02/28 Non-alcoholic Fatty Liver Disease: Emerging Biomarkers, Targets and Therapies
PTDC/MED-FAR/29097/2017
Universidade de Lisboa Faculdade de Farmácia, Portugal

Universidade de Lisboa Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2016/09/01 - 2019/08/31 Técnicas de Imagem Molecular da Fibrose Hepática
HMSP-ICT/0012/2013
Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal

Athinoula A Martinos Center for Biomedical Imaging, United States

Centro Hospitalar e Universitário de Coimbra EPE, Portugal

Universidade de Lisboa Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2016/07/01 - 2019/06/30 Novas Moléculas para Tratar Fígado Gordo não Alcoólico e Progressão para Cancro
PTDC/BIM-MEC/0895/2014
Centro Hospitalar de Lisboa Central EPE, Portugal

Centro Hospitalar Universitário Lisboa Norte EPE, Portugal

Harvard Medical School Department of Cell Biology, United States
Fundação para a Ciência e a Tecnologia
Concluded
2015 - 2019 Carbalive: clinical evaluation of nanoporous carbon adsorbent with tailored porosity (Yaq-0 liver disease 01) as a new therapeutic for the treatment of liver cirrhosis and non-alcoholic fatty disease
634579
Principal investigator
Universidade de Lisboa Faculdade de Medicina, Portugal
Concluded
2013/06/01 - 2016/11/30 TRATAR DOENÇAS HEPÁTICAS TENDO COMO ALVO A NECROPTOSE DOS HEPATÓCITOS
HMSP-ICT/0018/2011
Fundação Calouste Gulbenkian, Portugal

Harvard Medical School Department of Cell Biology, United States

Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2013/07/01 - 2015/12/31 Com o miR-21 e os receptores ativados pelos ácidos biliares em mira na patogénese do fígado gordo não alcoólico: duas balas para um homicídio?
PTDC/BIM-MEC/0873/2012
University of Minnesota Department of Medicine, United States

The University of Texas Southwestern Medical Center, United States

Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2012/03/01 - 2015/06/30 NecroPT - Modular da Necroptose no Tratamento de Doenças Hepáticas
PTDC/SAU-ORG/119842/2010
Universidade de Lisboa Faculdade de Farmácia, Portugal

Harvard Medical School Department of Cell Biology, United States

Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2011/01/03 - 2014/07/02 Modulação do microRNA-34, um Elo Potencial entre a Apoptose e a Patogénese do Fígado Gordo Não Alcoólico
PTDC/SAU-ORG/111930/2009
Universidade de Lisboa Faculdade de Farmácia, Portugal

University of Minnesota Department of Genetics Cell Biology and Development, United States

Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal
Fundação para a Ciência e a Tecnologia
Concluded
2009 - 2013 Prevalência e gravidade do fígado gordo na obesidade mórbida: correlações e mecanismos relacionados com o papel da gordura ectópica na resistência à insulina
PTDC/SAU-OSM/100878/2008
PTDC/SAU-OSM/100878/2008
Other
Universidade de Lisboa Faculdade de Medicina, Portugal

Universidade de Lisboa Instituto de Medicina Molecular João Lobo Antunes, Portugal

Universidade de Lisboa Faculdade de Farmácia, Portugal
N/A

Fundação para a Ciência e a Tecnologia
Concluded
2008/06/16 - 2012/02/14 Nutracêuticos: que papel na prevenção na doença crónica? - contributo para a fundamentação de uma nova opção terapêutica -
PTDC/SAU-OSM/66323/2006
Universidade Nova de Lisboa Faculdade de Ciências Médicas, Portugal

Fundação Calouste Gulbenkian, Portugal

Hospital Pulido Valente, Portugal

Instituto Nacional de Saúde Doutor Ricardo Jorge, Portugal

Instituto Português de Oncologia de Lisboa Francisco Gentil EPE, Portugal

Universidade de Lisboa Faculdade de Medicina, Portugal
Fundação para a Ciência e a Tecnologia
Concluded

Other

Designation Funders
2021/10/01 - Current Clinical trial: The effect of semaglutide in subjects with non-cirrhotic non-alcoholic steatohepatitis
Trial ID NN9931-4553
Principal investigator
Novo Nordisk A/S, Latvia
 Novo Nordisk A/S
Ongoing
2020/10/01 - Current Clinical trial 1404-P01-P02-P03
1404-0043
Principal investigator
Boehringer Ingelheim RCV GmbH und Co KG, Austria
 Boehringer Ingelheim RCV GmbH und Co KG
Ongoing
2016 - Current Ensaio clínico: Regenerate NASH Protocol 747-303
747-303
Other
Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
2016 - Current Ensaio clínico RESOLVE-IT
GFT505-315-1
Principal investigator
Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
Ongoing
2016 - Current Pro-Euro-DILI - Prospective European Drug-Induced Liver Injury
0
Principal investigator
Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
2012 - 2015 Estimativa da prevalência de esteatose hepática e das hepatites víricas na população portuguesa
0
Principal investigator
Instituto de Medicina Molecular João Lobo Antunes, Portugal
Concluded
2006 - 2008 ensaio da Sanofi-Aventis: CATs e SPARe-1 (Satavaptan) no tratamento da ascite
0
Principal investigator
Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
Concluded
Outputs

Publications

Book chapter
  1. Cortez-Pinto, Helena; Machado, M.V. "Evaluating the NAFLD patient: putting in perspective non-invasive and invasive methods". In Therapy in Liver Diseases. 2013.
  2. Cortez-Pinto, Helena. "Cirrose hepática". In Aparelho Digestivo. Clínica e Cirurgia. 2012.
  3. Cortez-Pinto, Helena. "Genética e Fígado gordo não alcoólico. Esteato-hepatite e suas correlações.". In Doença Hepática Gordurosa não alcoólica. 2011.
  4. Cortez-Pinto, Helena. "Resistência à insulina e esteatose na hepatite crónica C.". In Terapêutica de formas particulares de hepatites virais. 2009.
  5. Cortez-Pinto, Helena. "Epidemiology and risk factors of NASH". In Nonalcoholic steatohepatitis. In International Hepatology Updates. 2007.
  6. Cortez-Pinto, Helena. "Fígado gordo e NASH". In Tratado de Hepatologia.. 2006.
  7. Cortez-Pinto, Helena. "Esteatohepatite não alcoólica". In Diagnóstico em Hepatologia. 2004.
  8. Cortez-Pinto, Helena. "Tratamento da esteatohepatite alcoólica e não alcoólica". In Terapêutica Hepatológica. 2003.
  9. Cortez-Pinto, Helena. "Oxidative stress in alcoholic and non-alcoholic liver disease". In Steatohepatitis (NASH and ASH). 2002.
Conference paper
  1. Carvalhana, Sofia; Leitão, Jorge; Alves, Catarina; Bourbon, Mafalda; Cortez-Pinto, Helena. "Good correlation between plasma cytokeratin-18 and controlled attenuation parameter (CAP) in healthy population". 2014.
  2. Carvalhana, Sofia; Pinto, Rui; Leitão, Jorge; Silva, Ana Paula; Alves, Catarina; Bourbon, Mafalda; Carvalho, Armando; Cortez-Pinto, Helena. "HCV and HBV prevalence in the population: Large disparity between Hepatitis C in the general population, comparing with high risk groups". 2014.
  3. Carvalhana, Sofia; Leitão, Jorge; Alves, Catarina; Bourbon, Mafalda; Cortez-Pinto, Helena. "“Normal” controlled attenuation parameter (CAP) values: a population-based study of healthy subjects". 2014.
  4. Carvalhana, Sofia; Leitão, Jorge; Silva, Ana Paula; Alves, Catarina; Bourbon, Mafalda; Carvalho, Armando; Cortez-Pinto, Helena. "Prevalence of hepatic steatosis in the general Portuguese population: using fatty liver index (FLI) and ultrasound". 2014.
  5. Carvalhana, Sofia; Pinto, Rui; Leitão, Jorge; Silva, Ana Paula; Alves, Catarina; Bourbon, Mafalda; Carvalho, Armando; Cortez-Pinto, Helena. "Hepatitis B serologic markers after 14 years of universal new-born vaccination". 2014.
Conference poster
  1. Mafalda João; Sofia Carvalhana; Miguel Moura; Luís Carlos Freitas; Andrea Silva; Pedro Figueiredo; Rodrigo Liberal; et al. Corresponding author: Helena Cortez-Pinto. "FATORES PREDITORES DE AUSÊNCIA DE RESPOSTA A CORTICOTERAPIA NA HEPATITE AUTOIMUNE AGUDA GRAVE". Paper presented in Congresso Português de Hepatologia - 2ª Reunião Anual da APEF, 2021.
  2. Joshua Card Gowers; Daniel Ohrenstein; Laura Webber; Hannah Graff; Juan Vesga; Maria Buti; Cortez-Pinto, Helena; et al. "Projecting the prevalence of obesity and alcohol-related non-communicable diseases in France from 2020 to 2030 using multi-risk microsimulation methods: preliminary results". Paper presented in ECO Online 2021 - 28th European Congress on Obesity, 2021.
Journal article
  1. Samuel Raimundo Fernandes; Sónia Bernardo; Sofia Saraiva; Ana Rita Gonçalves; Paula Moura Santos; Ana Valente; Luís Araújo Correia; Helena Cortez-Pinto; Fernando Magro. "The degree of bowel remission predicts phenotype progression in Crohn's disease". United European Gastroenterology Journal (2024): https://doi.org/10.1002/ueg2.12581.
    10.1002/ueg2.12581
  2. Samuel Raimundo Fernandes; Sónia Bernardo; Sofia Saraiva; Ana Rita Gonçalves; Paula Moura Santos; Ana Valente; Luís Araújo Correia; Helena Cortez-Pinto; Fernando Magro. "Tight control using fecal calprotectin and early disease intervention increase the rates of transmural remission in Crohn's disease". United European Gastroenterology Journal (2024): https://doi.org/10.1002/ueg2.12497.
    10.1002/ueg2.12497
  3. Lise Retat; Laura Webber; Peter Jepsen; Alexander Martin; Helena Cortez-Pinto; Jeffrey V. Lazarus; Francesco Negro; et al. "Preventing liver disease with policy measures to tackle alcohol consumption and obesity: The HEPAHEALTH II study". Journal of Hepatology (2024): https://doi.org/10.1016/j.jhep.2023.11.021.
    10.1016/j.jhep.2023.11.021
  4. Vlad Ratziu; Sven Francque; Cynthia A. Behling; Vanja Cejvanovic; Helena Cortez-Pinto; Janani S. Iyer; Niels Krarup; et al. "Artificial intelligence scoring of liver biopsies in a phase II trial of semaglutide in nonalcoholic steatohepatitis". Hepatology (2023): https://doi.org/10.1097/HEP.0000000000000723.
    10.1097/HEP.0000000000000723
  5. Samuel Raimundo Fernandes; Sónia Bernardo; Sofia Saraiva; Ana Rita Gonçalves; Paula Moura Santos; Ana Valente; Luís Araújo Correia; Helena Cortez-Pinto; Fernando Magro. "Proactive Infliximab Monitoring Improves the Rates of Transmural Remission in Crohn’s Disease: A Propensity Score–Matched Analysis". Inflammatory Bowel Diseases (2023): https://doi.org/10.1093/ibd/izad272.
    10.1093/ibd/izad272
  6. Ana Craciun; Inês Botto; Joao Lopes; Miguel Moura; Sofia Carvalhana; Helena Cortez-Pinto; Rui Tato Marinho. "Influence of COVID-19 on Patients with Esophageal Varices under Prophylactic Endoscopic Band Ligation Therapy". GE - Portuguese Journal of Gastroenterology (2023): https://doi.org/10.1159/000531135.
    10.1159/000531135
  7. Einar S. Björnsson; Camilla Stephens; Edmond Atallah; Mercedes Robles-Diaz; Ismael Alvarez-Alvarez; Alexander Gerbes; Sabine Weber; et al. "A new framework for advancing in drug-induced liver injury research. The Prospective European DILI Registry". Liver International (2023): https://doi.org/10.1111/liv.15378.
    10.1111/liv.15378
  8. Mariana Verdelho Machado; Helena Cortez-Pinto. "NAFLD, MAFLD and obesity: brothers in arms?". Nature Reviews Gastroenterology & Hepatology (2022): https://doi.org/10.1038/s41575-022-00717-4.
    10.1038/s41575-022-00717-4
  9. Helena Cortez-Pinto; Jeanin van Hooft; Berthold Koletzko; Johannes-Matthias Löhr. "UEG's prospects for the future". United European Gastroenterology Journal (2022): https://doi.org/10.1002/ueg2.12335.
    10.1002/ueg2.12335
  10. Helena Cortez-Pinto. "My UEG Presidency: Providing opportunities for professionals to enhance their knowledge and skills and ultimately contribute to the improvement of digestive health". United European Gastroenterology Journal 10 2 (2022): 233-234. https://doi.org/10.1002/ueg2.12210.
    10.1002/ueg2.12210
  11. Sara Policarpo; sofia carvalhana; Ana Craciun; Ricardo Rios Crespo; Helena Cortez-Pinto. "Do MAFLD Patients with Harmful Alcohol Consumption Have a Different Dietary Intake?". Nutrients (2022): https://www.mdpi.com/2072-6643/14/7/1335.
    10.3390/nu14071335
  12. Ventura-Cots, Meritxell; Argemi, Josepmaria; Jones, Patricia D; Lackner, Carolin; El Hag, Mohamed; Abraldes, Juan G; Alvarado, Edilmar; et al. "Clinical, histological and molecular profiling of different stages of alcohol-related liver disease". (2022): http://hdl.handle.net/10451/51101.
    10.1136/gutjnl-2021-324295
  13. Sara Raquel Osório Policarpo; Mariana V. Machado; David Barreira; Helena Cortez-Pinto. "NAFLD Nutritional Management: Results from a Multidisciplinary Approach". GE - Portuguese Journal of Gastroenterology (2021): https://doi.org/10.1159/000519932.
    10.1159/000519932
  14. Lazarus, Jeffrey V.; Mark, Henry E.; Anstee, Quentin M.; Arab, Juan Pablo; Batterham, Rachel L.; Castera, Laurent; Cortez-Pinto, Helena; et al. "Advancing the global public health agenda for NAFLD: a consensus statement". Nature Reviews Gastroenterology & Hepatology 19 1 (2021): 60-78. http://dx.doi.org/10.1038/s41575-021-00523-4.
    10.1038/s41575-021-00523-4
  15. Helena Cortez-Pinto; Rodrigo Liberal; Susana Lopes; Mariana V. Machado; Joana Carvalho; Teresa Dias; Arsénio Santos; et al. "Predictors for incomplete response to ursodeoxycholic acid in primary biliary cholangitis. Data from a national registry of liver disease". United European Gastroenterology Journal 9 6 (2021): 699-706. https://doi.org/10.1002/ueg2.12095.
    10.1002/ueg2.12095
  16. Hirschfield, Gideon M; Chazouillères, Olivier; Cortez-Pinto, Helena; Macedo, Guilherme; de Lédinghen, Victor; Adekunle, Femi; Carbone, Marco. "A consensus integrated care pathway for patients with primary biliary cholangitis: a guideline-based approach to clinical care of patients". Expert Review of Gastroenterology & Hepatology 15 8 (2021): 929-939. http://dx.doi.org/10.1080/17474124.2021.1945919.
    10.1080/17474124.2021.1945919
  17. Lazarus, Jeffrey V.; Anstee, Quentin M.; Hagström, Hannes; Cusi, Kenneth; Cortez-Pinto, Helena; Mark, Henry E.; Roden, Michael; et al. "Defining comprehensive models of care for NAFLD". Nature Reviews Gastroenterology & Hepatology 18 10 (2021): 717-729. http://dx.doi.org/10.1038/s41575-021-00477-7.
    10.1038/s41575-021-00477-7
  18. Sónia Bernardo; Rudolf E. Stauber; Ricardo Crespo; Sofia Saraiva; Rui Barata; Sara Gonçalves; Paulo Nogueira; Helena Cortez-Pinto; Mariana Verdelho Machado. "Outcomes of excessive alcohol drinkers without baseline evidence of chronic liver disease after 15 years follow-up: Heavy burden of cancer and liver disease mortality". PLOS ONE (2021): https://doi.org/10.1371/journal.pone.0252218.
    10.1371/journal.pone.0252218
  19. Vanholder, Raymond; Domínguez-Gil, Beatriz; Busic, Mirela; Cortez-Pinto, Helena; Craig, Jonathan C.; Jager, Kitty J.; Mahillo, Beatriz; et al. "Organ donation and transplantation: a multi-stakeholder call to action". Nature Reviews Nephrology 17 8 (2021): 554-568. http://dx.doi.org/10.1038/s41581-021-00425-3.
    10.1038/s41581-021-00425-3
  20. Reis, Daniela; Moura, Miguel; Freitas, Luís Carlos; Carvalhana, Sofia; Nogueira, Paulo Jorge; Gaio, Raquel; Marinho, Rui Tato; Cortez-Pinto, Helena. "Predictive factors for long-term survival in patients with advanced hepatocellular carcinoma treated with sorafenib". European Journal of Gastroenterology & Hepatology Publish Ah (2020): http://dx.doi.org/10.1097/meg.0000000000001974.
    10.1097/meg.0000000000001974
  21. Hardy, Timothy; Wonders, Kristy; Younes, Ramy; Aithal, Guruprasad P.; Aller, Rocio; Allison, Michael; Bedossa, Pierre; et al. "The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease". Contemporary Clinical Trials 98 (2020): 106175. http://dx.doi.org/10.1016/j.cct.2020.106175.
    Published • 10.1016/j.cct.2020.106175
  22. Jeffrey V. Lazarus; Massimo Colombo; Helena Cortez-Pinto; Terry T. -K. Huang; Veronica Miller; Michael Ninburg; Jörn M. Schattenberg; et al. "NAFLD — sounding the alarm on a silent epidemic". Nature Reviews Gastroenterology & Hepatology (2020): https://doi.org/10.1038/s41575-020-0315-7.
    10.1038/s41575-020-0315-7
  23. Ana Craciun; Caroline Lackner; Helena Cortez-Pinto. "Nonalcoholic Fatty Liver Disease versus Alcohol-related Liver Disease: Is it Really so Different?". Current Pharmaceutical Design 26 (2020): https://doi.org/10.2174/1381612826666200122152417.
    10.2174/1381612826666200122152417
  24. Leitão, Jorge; Carvalhana, Sofia; Cochicho, Joana; Silva, Ana Paula; Velasco, Francisco; Medeiros, Isabel; Alves, Ana Catarina; et al. "Prevalence and risk factors of fatty liver in Portuguese adults". European Journal of Clinical Investigation (2020): http://dx.doi.org/10.1111/eci.13235.
    10.1111/eci.13235
  25. Jeffrey V. Lazarus; Helena Cortez-Pinto; Quentin M. Anstee. "Reply to: “Caveats for the implementation of global strategies against non-alcoholic fatty liver disease”". Journal of Hepatology (2020): https://doi.org/10.1016/j.jhep.2020.03.017.
    10.1016/j.jhep.2020.03.017
  26. Eslam, Mohammed; Newsome, Philip N.; Anstee, Quentin M.; Targher, Giovanni; Gomez, Manuel Romero; Zelber-Sagi, Shira; Wong, Vincent Wai-Sun; et al. "A new definition for metabolic associated fatty liver disease: an international expert consensus statement". Journal of Hepatology (2020): http://dx.doi.org/10.1016/j.jhep.2020.03.039.
    10.1016/j.jhep.2020.03.039
  27. Eslam, Mohammed; Sanyal, Arun J.; George, Jacob; Sanyal, Arun; Neuschwander-Tetri, Brent; Tiribelli, Claudio; Kleiner, David E.; et al. "MAFLD: A Consensus-Driven Proposed Nomenclature for Metabolic Associated Fatty Liver Disease". Gastroenterology (2020): http://dx.doi.org/10.1053/j.gastro.2019.11.312.
    10.1053/j.gastro.2019.11.312
  28. Carlos Noronha Ferreira; Helena Cortez-Pinto; José Velosa; Rui Tato Marinho. "Inadvertent oversight while reporting factors predicting decompensation of cirrhosis". Liver International (2020): https://doi.org/10.1111/liv.14287.
    10.1111/liv.14287
  29. Marques da Costa, Pedro; Tato Marinho, Rui; Cortez-Pinto, Helena; Costa, Luís; Velosa, José; Marinho, Rui. "Twenty-Five Years of Increasing Mortality From Pancreatic Cancer in Portugal". Pancreas 49 1 (2020): e2-e3. http://dx.doi.org/10.1097/mpa.0000000000001446.
    10.1097/mpa.0000000000001446
  30. Lazarus, Jeffrey V.; Ekstedt, Mattias; Marchesini, Giulio; Mullen, Jillian; Novak, Katja; Pericàs, Juan M.; Roel, Elena; et al. "A cross-sectional study of the public health response to non-alcoholic fatty liver disease in Europe". Journal of Hepatology 72 1 (2020): 14-24. http://dx.doi.org/10.1016/j.jhep.2019.08.027.
    10.1016/j.jhep.2019.08.027
  31. Avila, Matias A; Dufour, Jean-François; Gerbes, Alexander L; Zoulim, Fabien; Bataller, Ramon; Burra, Patrizia; Cortez-Pinto, Helena; et al. "Recent advances in alcohol-related liver disease (ALD): summary of a Gut round table meeting". Gut 69 4 (2019): 764-780. http://dx.doi.org/10.1136/gutjnl-2019-319720.
    10.1136/gutjnl-2019-319720
  32. Younossi, Zobair M; Ratziu, Vlad; Loomba, Rohit; Rinella, Mary; Anstee, Quentin M; Goodman, Zachary; Bedossa, Pierre; et al. "Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial". The Lancet 394 10215 (2019): 2184-2196. http://dx.doi.org/10.1016/s0140-6736(19)33041-7.
    10.1016/s0140-6736(19)33041-7
  33. Marchesini, Giulio; Petroni, Maria Letizia; Cortez-Pinto, Helena. "Adipose tissue-associated cancer risk: Is it the fat around the liver, or the fat inside the liver?". Journal of Hepatology 71 6 (2019): 1073-1075. http://dx.doi.org/10.1016/j.jhep.2019.09.020.
    10.1016/j.jhep.2019.09.020
  34. Machado, Mariana V.; Policarpo, Sara; Coutinho, J; Carvalhana, Sofia; Leitão, Jorge; Carvalho, Armando; Silva, Ana P.; et al. "What Is the Role of the New Index Relative Fat Mass (RFM) in the Assessment of Nonalcoholic Fatty Liver Disease (NAFLD)?". Obesity Surgery 30 2 (2019): 560-568. http://dx.doi.org/10.1007/s11695-019-04213-8.
    10.1007/s11695-019-04213-8
  35. Carlos Noronha Ferreira; Helena Cortez-Pinto; Fátima Serejo; José Velosa; Rui Tato Marinho. "Anticoagulation in patients with cirrhosis and portal vein thrombosis: Safety and beneficial effect on OLT-free survival". Liver International 39 10 (2019): 2002-2002. https://doi.org/10.1111/liv.14231.
    10.1111/liv.14231
  36. Vasques, João; Guerreiro, Catarina Sousa; Sousa, Joana; Pinto, Mariana; Cortez-Pinto, Helena. "Nutritional support in cirrhotic patients with sarcopenia". Clinical Nutrition ESPEN 33 (2019): 12-17. http://dx.doi.org/10.1016/j.clnesp.2019.07.011.
    10.1016/j.clnesp.2019.07.011
  37. Shah, Neil D.; Ventura-Cots, Meritxell; Abraldes, Juan G.; Alboraie, Mohamed; Alfadhli, Ahmad; Argemi, Josepmaria; Badia-Aranda, Ester; et al. "Alcohol-Related Liver Disease Is Rarely Detected at Early Stages Compared With Liver Diseases of Other Etiologies Worldwide". Clinical Gastroenterology and Hepatology 17 11 (2019): 2320-2329.e12. http://dx.doi.org/10.1016/j.cgh.2019.01.026.
    10.1016/j.cgh.2019.01.026
  38. Carlos Noronha Ferreira; Rui T. Marinho; Helena Cortez-Pinto; Paula Ferreira; Margarida S. Dias; Mariana Vasconcelos; Paula Alexandrino; et al. "Incidence, predictive factors and clinical significance of development of portal vein thrombosis in cirrhosis: A prospective study". Liver International (2019): https://doi.org/10.1111/liv.14121.
    10.1111/liv.14121
  39. Simão, André L.; Afonso, Marta B.; Rodrigues, Pedro M.; Gama-Carvalho, Margarida; Machado, Mariana V.; Cortez-Pinto, Helena; Rodrigues, Cecília M. P.; Castro, Rui E.. "Skeletal muscle miR-34a/SIRT1:AMPK axis is activated in experimental and human non-alcoholic steatohepatitis". Journal of Molecular Medicine 97 8 (2019): 1113-1126. http://dx.doi.org/10.1007/s00109-019-01796-8.
    10.1007/s00109-019-01796-8
  40. Arab, Juan P.; Roblero, Juan P.; Altamirano, Jose; Bessone, Fernando; Chaves Araujo, Roberta; Higuera-De la Tijera, Fatima; Restrepo, Juan Carlos; et al. "Alcohol-related liver disease: Clinical practice guidelines by the Latin American Association for the Study of the Liver (ALEH)". Annals of Hepatology 18 3 (2019): 518-535. http://dx.doi.org/10.1016/j.aohep.2019.04.005.
    10.1016/j.aohep.2019.04.005
  41. Noronha Ferreira, Carlos; Reis, Daniela; Cortez-Pinto, Helena; Tato Marinho, Rui; Gonçalves, Afonso; Palma, Sónia; Leite, Inês; et al. "Anticoagulation in Cirrhosis and Portal Vein Thrombosis Is Safe and Improves Prognosis in Advanced Cirrhosis". Digestive Diseases and Sciences 64 9 (2019): 2671-2683. http://dx.doi.org/10.1007/s10620-019-05572-z.
    10.1007/s10620-019-05572-z
  42. Szabo, Gyongyi; Kamath, Patrick S.; Shah, Vijay H.; Thursz, Mark; Mathurin, Philippe; Addolorato, Giovanni; Bataller, Ramon; et al. "Alcohol-Related Liver Disease: Areas of Consensus, Unmet Needs and Opportunities for Further Study". Hepatology 69 5 (2019): 2271-2283. http://dx.doi.org/10.1002/hep.30369.
    10.1002/hep.30369
  43. Bazerbachi, Fateh; Haffar, Samir; Wang, Zhen; Cabezas, Joaquín; Arias-Loste, Maria Teresa; Crespo, Javier; Darwish-Murad, Sarwa; et al. "Range of Normal Liver Stiffness and Factors Associated With Increased Stiffness Measurements in Apparently Healthy Individuals". Clinical Gastroenterology and Hepatology 17 1 (2019): 54-64.e1. http://dx.doi.org/10.1016/j.cgh.2018.08.069.
    10.1016/j.cgh.2018.08.069
  44. Joana Rita Carvalho; Mariana Vasconcelos; Pedro Marques da Costa; Rui Tato Marinho; Narcisa Fatela; Miguel Raimundo; Sofia Carvalhana; et al. "Identifying palliative care needs in a Portuguese liver unit". Liver International (2018): https://doi.org/10.1111/liv.13865.
    10.1111/liv.13865
  45. Pimpin, Laura; Cortez-Pinto, Helena; Negro, Francesco; Corbould, Emily; Lazarus, Jeffrey V.; Webber, Laura; Sheron, Nick. "Burden of liver disease in Europe: Epidemiology and analysis of risk factors to identify prevention policies". Journal of Hepatology 69 3 (2018): 718-735. http://dx.doi.org/10.1016/j.jhep.2018.05.011.
    10.1016/j.jhep.2018.05.011
  46. Seitz, Helmut K.; Bataller, Ramon; Cortez-Pinto, Helena; Gao, Bin; Gual, Antoni; Lackner, Carolin; Mathurin, Philippe; et al. "Alcoholic liver disease". Nature Reviews Disease Primers 4 1 (2018): http://dx.doi.org/10.1038/s41572-018-0014-7.
    10.1038/s41572-018-0014-7
  47. Pedro Marques da Costa; Inês Martins; Joaquim Neves; Helena Cortez-Pinto; José Velosa; Marques da Costa, Pedro; Martins, Inês; et al. "Serum Vitamin D Levels Correlate With The Presence And Histological Grading Of Colorectal Adenomas In Peri And Postmenopausal Women". Clinical Nutrition 38 3 (2018): 1390-1397. https://doi.org/10.1016/j.clnu.2018.06.959.
    10.1016/j.clnu.2018.06.959
  48. Leitão, Jorge; Carvalhana, Sofia; Silva, Ana Paula; Velasco, Francisco; Medeiros, Isabel; Alves, Ana Catarina; Bourbon, Mafalda; et al. "No Evidence for Lower Levels of Serum Vitamin D in the Presence of Hepatic Steatosis. A Study on the Portuguese General Population". (2018): http://hdl.handle.net/10400.18/5932.
    10.7150/ijms.26586
  49. Bernardo, Sónia; Carvalhana, Sofia; Antunes, Teresa; Ferreira, Paula; Cortez-Pinto, Helena; Velosa, José. "A rare cause of acute liver failure- a case report". BMC Gastroenterology 17 1 (2017): http://dx.doi.org/10.1186/s12876-017-0730-6.
    10.1186/s12876-017-0730-6
  50. Fernandes, Samuel R.; Marques da Costa, Pedro; Vítor, Sofia; Carvalho, Joana R.; Santos, Patrícia; Moura, Carlos M.; Cortez-Pinto, Helena; Ramalho, Fernando; Velosa, José. "Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis". European Journal of Gastroenterology & Hepatology 29 10 (2017): 1141-1148. http://dx.doi.org/10.1097/meg.0000000000000926.
    10.1097/meg.0000000000000926
  51. Rodrigues, Pedro M; Afonso, Marta B; Simão, André L; Carvalho, Catarina C; Trindade, Alexandre; Duarte, António; Borralho, Pedro M; et al. "Erratum: miR-21 ablation and obeticholic acid ameliorate nonalcoholic steatohepatitis in mice". Cell Death & Disease 8 5 (2017): e2825-e2825. http://dx.doi.org/10.1038/cddis.2017.246.
    10.1038/cddis.2017.246
  52. Chora, Joana Rita; Alves, Ana Catarina; Medeiros, Ana Margarida; Mariano, Cibelle; Lobarinhas, Goreti; Guerra, António; Mansilha, Helena; Cortez-Pinto, Helena; Bourbon, Mafalda. "Lysosomal acid lipase deficiency: A hidden disease among cohorts of familial hypercholesterolemia?". Journal of Clinical Lipidology 11 2 (2017): 477-484.e2. http://dx.doi.org/10.1016/j.jacl.2016.11.002.
    10.1016/j.jacl.2016.11.002
  53. Telles-Correia, Diogo; Barbosa, António; Cortez-Pinto, Helena; Campos, Carlos; Rocha, Nuno B F; Machado, Sérgio; Rocha, Nuno. "Psychotropic drugs and liver disease : a critical review of pharmacokinetics and liver toxicity". (2017): http://hdl.handle.net/10451/45820.
    10.4292/wjgpt.v8.i1.26
  54. Bugianesi, E.; Rosso, C.; Cortez-Pinto, H.. "How to diagnose NAFLD in 2016". Journal of Hepatology 65 3 (2016): 643-644. http://dx.doi.org/10.1016/j.jhep.2016.05.038.
    10.1016/j.jhep.2016.05.038
  55. Fernandes, Samuel Raimundo; Alves, Antonio T; Cortes, Margarida Barreto; Cortez-Pinto, Helena. "Graft-versus-host disease: unexpected presentation with simultaneous hepatitis and pancreatitis". BMJ Case Reports (2016): bcr2016215940. http://dx.doi.org/10.1136/bcr-2016-215940.
    10.1136/bcr-2016-215940
  56. Carvalhana, Sofia C.; Leitão, Jorge; Alves, Ana C.; Bourbon, Mafalda; Cortez-Pinto, Helena. "Hepatitis B and C prevalence in Portugal". European Journal of Gastroenterology & Hepatology 28 6 (2016): 640-644. http://dx.doi.org/10.1097/meg.0000000000000608.
    10.1097/meg.0000000000000608
  57. Lonardo, A.; Byrne, C.D.; Caldwell, S.H.; Cortez-Pinto, H.; Targher, G.. "Global epidemiology of nonalcoholic fatty liver disease: Meta-analytic assessment of prevalence, incidence, and outcomes". Hepatology 64 4 (2016): 1388-1389. http://dx.doi.org/10.1002/hep.28584.
    10.1002/hep.28584
  58. Machado, Mariana; Cortez-Pinto, Helena; Cortez-Pinto, Helena. "Diet, Microbiota, Obesity, and NAFLD: A Dangerous Quartet". International Journal of Molecular Sciences 17 4 (2016): 481. http://dx.doi.org/10.3390/ijms17040481.
    10.3390/ijms17040481
  59. Fernandes, Samuel Raimundo; Correia, Luís Araújo; Antunes, Teresa; Cortez-Pinto, Helena. "Intraductal papillary mucinous neoplasm presenting with recurrent pancreatitis: a report of a painful 3-decade-long history". BMJ Case Reports (2016): bcr2016214640. http://dx.doi.org/10.1136/bcr-2016-214640.
    10.1136/bcr-2016-214640
  60. Fernandes, Samuel Raimundo; Moura, Carlos Miguel; Rodrigues, Beatriz; Correia, Luís Araújo; Cortez-Pinto, Helena; Velosa, José. "Acute cholangitis in an old patient with Crigler-Najjar syndrome type II - a case report". BMC Gastroenterology 16 1 (2016): http://dx.doi.org/10.1186/s12876-016-0449-9.
    10.1186/s12876-016-0449-9
  61. Cortez-Pinto, Helena; Borralho, Paula; Machado, Jorge; Lopes, Maria T.; Gato, Inês V.; Santos, António M.; Guerreiro, António S.; et al. "Microbiota Modulation With Synbiotic Decreases Liver Fibrosis in a High Fat Choline Deficient Diet Mice Model of Non-Alcoholic Steatohepatitis (NASH)". (2016): http://hdl.handle.net/10362/124600.
    https://doi.org/10.1016/j.jpge.2016.01.004
  62. Afonso, Marta; Rodrigues, Pedro; Simão, André; Ofengeim, Dimitry; Carvalho, Tânia; Amaral, Joana D.; Gaspar, Maria Manuela; et al. "Activation of necroptosis in human and experimental cholestasis". Cell Death & Disease 7 9 (2016): e2390-e2390. http://hdl.handle.net/10451/46134.
    10.1038/cddis.2016.280
  63. Pimenta, Nuno; Santa-Clara, Helena; Melo, Xavier; Cortez-Pinto, Helena; Silva Nunes, José António; Sardinha, Luis; Pimenta, N M; et al. "Waist-to-Hip Ratio is Related to Body Fat Content and Distribution Regardless of the Waist Circumference Measurement Protocol, in Non-Alcoholic Fatty Liver Disease Patients". International Journal of Sport Nutrition and Exercise Metabolism 26 4 (2016): 307-314. http://hdl.handle.net/10400.15/2149.
    10.1123/ijsnem.2014-0256
  64. Machado, Mariana Verdelho; Michelotti, Gregory Alexander; Pereira, Thiago Almeida; Xie, Guanhua; Premont, Richard; Cortez-Pinto, Helena; Diehl, Anna Mae. "Accumulation of duct cells with activated YAP parallels fibrosis progression in non-alcoholic fatty liver disease". Journal of Hepatology 63 4 (2015): 962-970. http://dx.doi.org/10.1016/j.jhep.2015.05.031.
    10.1016/j.jhep.2015.05.031
  65. Machado, Mariana V.; Cortez-Pinto, Helena. "Proangiogenic factors in the development of HCC in alcoholic cirrhosis". Clinics and Research in Hepatology and Gastroenterology 39 (2015): S104-S108. http://dx.doi.org/10.1016/j.clinre.2015.06.001.
    10.1016/j.clinre.2015.06.001
  66. Afonso, Marta B.; Rodrigues, Pedro M.; Carvalho, Tânia; Caridade, Marta; Borralho, Paula; Cortez-Pinto, Helena; Castro, Rui E.; Rodrigues, Cecília M.P.. "Necroptosis is a key pathogenic event in human and experimental murine models of non-alcoholic steatohepatitis". Clinical Science 129 8 (2015): 721-739. http://dx.doi.org/10.1042/cs20140732.
    10.1042/cs20140732
  67. Loomba, Rohit; Cortez-Pinto, Helena. "Exercise and improvement of NAFLD: Practical recommendations". Journal of Hepatology 63 1 (2015): 10-12. http://dx.doi.org/10.1016/j.jhep.2015.03.009.
    10.1016/j.jhep.2015.03.009
  68. Telles-Correia, D.; João Freire, M.; Mega, I.; Barreiras, D.; Cortez Pinto, H.. "Anxiety and Depression Symptoms in Hepatic Encephalopathy: Are They Psychiatric or Organic?". Transplantation Proceedings 47 4 (2015): 1005-1007. http://dx.doi.org/10.1016/j.transproceed.2015.03.011.
    10.1016/j.transproceed.2015.03.011
  69. Cavalcante, Lourianne Nascimento. "Genetic ancestry analysis in non-alcoholic fatty liver disease patients from Brazil and Portugal". World Journal of Hepatology 7 10 (2015): 1433. http://dx.doi.org/10.4254/wjh.v7.i10.1433.
    10.4254/wjh.v7.i10.1433
  70. Machado, Mariana V.; Cortez-Pinto, Helena. "Nuclear receptors: how do they position in non-alcoholic fatty liver disease treatment?". Liver International 34 9 (2014): 1291-1294. http://dx.doi.org/10.1111/liv.12578.
    10.1111/liv.12578
  71. Musso, Giovanni; Gambino, Roberto; Tabibian, James H.; Ekstedt, Mattias; Kechagias, Stergios; Hamaguchi, Masahide; Hultcrantz, Rolf; et al. "Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis". PLoS Medicine 11 7 (2014): e1001680. http://dx.doi.org/10.1371/journal.pmed.1001680.
    10.1371/journal.pmed.1001680
  72. Machado, Mariana V.; Janeiro, André; Miltenberger-Miltenyi, Gabriel; Cortez-Pinto, Helena. "Genetic polymorphisms of proangiogenic factors seem to favor hepatocellular carcinoma development in alcoholic cirrhosis". European Journal of Gastroenterology & Hepatology 26 4 (2014): 438-443. http://dx.doi.org/10.1097/meg.0000000000000044.
    10.1097/meg.0000000000000044
  73. Machado, Mariana Verdelho; Cortez-Pinto, Helena. "Management of fatty liver disease with the metabolic syndrome". Expert Review of Gastroenterology & Hepatology 8 5 (2014): 487-500. http://dx.doi.org/10.1586/17474124.2014.903798.
    10.1586/17474124.2014.903798
  74. Machado, Mariana Verdelho. "Non-alcoholic fatty liver disease: What the clinician needs to know". World Journal of Gastroenterology 20 36 (2014): 12956. http://dx.doi.org/10.3748/wjg.v20.i36.12956.
    10.3748/wjg.v20.i36.12956
  75. Carvalhana, Sofia; Leitão, Jorge; Alves, Ana C.; Bourbon, Mafalda; Cortez-Pinto, Helena. "How good is controlled attenuation parameter and fatty liver index for assessing liver steatosis in general population: correlation with ultrasound". Liver International 34 6 (2013): e111-e117. http://dx.doi.org/10.1111/liv.12305.
    10.1111/liv.12305
  76. Machado, Mariana Verdelho; Cortez-Pinto, Helena. "Leptin in the treatment of lipodystrophy-associated nonalcoholic fatty liver disease: are we there already?". Expert Review of Gastroenterology & Hepatology 7 6 (2013): 513-515. http://dx.doi.org/10.1586/17474124.2013.814903.
    10.1586/17474124.2013.814903
  77. Cortez-Pinto H; Machado MV. "Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal.". (2013): http://europepmc.org/abstract/med/23183525.
    10.1016/j.jhep.2012.11.021
  78. Afonso MB; Borralho PM; Castro RE; Cortez-Pinto H; Ferreira DM; Machado MV; Rodrigues CM. "miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease.". (2013): http://europepmc.org/abstract/med/22902550.
    10.1016/j.jhep.2012.08.008
  79. Alexandrino P; Cortez-Pinto H; Noronha Ferreira C; Ramalho F; Rodrigues T; Serejo F; Velosa J. "The new definition of acute kidney injury in patients with cirrhosis: a critical look.". (2012): http://europepmc.org/abstract/med/22287595.
    10.1136/gutjnl-2011-301951
  80. Carepa F; Cortez-Pinto H; Costa A; Coutinho J; Machado MV; Proença H. "How adiponectin, leptin, and ghrelin orchestrate together and correlate with the severity of nonalcoholic fatty liver disease.". (2012): http://europepmc.org/abstract/med/22735605.
    10.1097/MEG.0b013e32835609b0
  81. Carvalhana S; Cortez-Pinto H; Machado MV. "Improving dietary patterns in patients with nonalcoholic fatty liver disease.". (2012): http://europepmc.org/abstract/med/22878240.
    10.1097/MCO.0b013e3283566614
  82. Carvalhana, Sofia; Machado, Mariana Verdelho; Cortez-Pinto, Helena. "Improving dietary patterns in patients with nonalcoholic fatty liver disease". Current Opinion in Clinical Nutrition and Metabolic Care 15 5 (2012): 468-473. http://dx.doi.org/10.1097/mco.0b013e3283566614.
    10.1097/mco.0b013e3283566614
  83. Cortez-Pinto H; Machado MV. "NKT cells and the hedgehog pathway: an unhealthy marriage in non-alcoholic fatty liver disease?". (2012): http://europepmc.org/abstract/med/22490528.
    10.1136/gutjnl-2012-302378
  84. Cortez-Pinto, Helena; Thursz, Mark; Gual, Antoni; Lackner, Caroline; Mathurin, Philippe; Moreno, Christophe; Spahr, Laurent; Sterneck, Martina; Cortez-Pinto, Helena. "EASL clinical practical guidelines: management of alcoholic liver disease.". Journal of Hepatology 57 2 (2012): 399-420. http://europepmc.org/abstract/med/22633836.
    10.1016/j.jhep.2012.04.004
  85. Pena, Maria João; Ravasco, Paula; Machado, Mariana; Pinto, Anabela; Pinto, Susana; Rocha, Luz; de Carvalho, Mamede; Pinto, Helena Cortez. "What is the relevance of percutaneous endoscopic gastrostomy on the survival of patients with amyotrophic lateral sclerosis?". Amyotrophic Lateral Sclerosis 13 6 (2012): 550-554. http://dx.doi.org/10.3109/17482968.2012.684215.
    10.3109/17482968.2012.684215
  86. Cortez-Pinto, Helena; Cortez-Pinto H. "Alcoholic disease: understanding the scope of the problem and what we need to do to tackle it". Therapeutic Advances in Chronic Disease 3 2 (2012): 53-58. http://dx.doi.org/10.1177/2040622311430441.
    10.1177/2040622311430441
  87. Machado, Mariana Verdelho; Ferreira, Duarte M. S.; Castro, Rui E.; Silvestre, Ana Rita; Evangelista, Teresinha; Coutinho, João; Carepa, Fátima; et al. "Liver and Muscle in Morbid Obesity: The Interplay of Fatty Liver and Insulin Resistance". PLoS ONE 7 2 (2012): e31738. http://dx.doi.org/10.1371/journal.pone.0031738.
    10.1371/journal.pone.0031738
  88. Carepa F; Cortez-Pinto H; Costa A; Coutinho J; Gonçalves S; Machado MV. "Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease.". (2012): http://europepmc.org/abstract/med/22098270.
    10.1111/j.1478-3231.2011.02623.x
  89. Cortez-Pinto H; Machado MV. " Gut microbiota and nonalcoholic fatty liver disease.". (2012): http://europepmc.org/abstract/med/22700625.
  90. Alvares-da-Silva, Mario Reis; Wedemeyer, Heiner; Cortez-Pinto, Helena; Marques Souza de Oliveira, Claudia Pinto; Alvares-da-Silva MR; Cortez-Pinto H; Marques Souza de Oliveira CP; Wedemeyer H. "Hepatitis C and Metabolic Disorders: Genetics, Mechanism, and Therapies (Clinical and Experimental)". International Journal of Hepatology 2012 (2012): 1-2. http://dx.doi.org/10.1155/2012/937202.
    10.1155/2012/937202
  91. Cortez-Pinto H; Machado MV; Oliveira AG; Machado, Mariana V.; Oliveira, António G.; Cortez-Pinto, Helena. "Hepatic steatosis in hepatitis B virus infected patients: meta-analysis of risk factors and comparison with hepatitis C infected patients.". Journal of Gastroenterology and Hepatology (2011): no-no. http://europepmc.org/abstract/med/21649726.
    10.1111/j.1440-1746.2011.06801.x
  92. Machado, Mariana V.; Gonçalves, Sara; Carepa, Fátima; Coutinho, João; Costa, Adília; Cortez-Pinto, Helena. "Impaired renal function in morbid obese patients with nonalcoholic fatty liver disease". Liver International 32 2 (2011): 241-248. http://dx.doi.org/10.1111/j.1478-3231.2011.02623.x.
    10.1111/j.1478-3231.2011.02623.x
  93. Cortez-Pinto H; Machado MV. "No need for a large belly to have NASH.". (2011): http://europepmc.org/abstract/med/21281684.
    10.1016/j.jhep.2011.01.010
  94. Ferreira, D. M. S.; Castro, R. E.; Machado, M. V.; Evangelista, T.; Silvestre, A.; Costa, A.; Coutinho, J.; et al. "Apoptosis and insulin resistance in liver and peripheral tissues of morbidly obese patients is associated with different stages of non-alcoholic fatty liver disease". Diabetologia 54 7 (2011): 1788-1798. http://dx.doi.org/10.1007/s00125-011-2130-8.
    10.1007/s00125-011-2130-8
  95. Machado, Mariana Verdelho; Cortez-Pinto, Helena; Cortez-Pinto H; Machado MV. "Cell death and nonalcoholic steatohepatitis: where is ballooning relevant?". Expert Review of Gastroenterology & Hepatology 5 2 (2011): 213-222. http://dx.doi.org/10.1586/egh.11.16.
    10.1586/egh.11.16
  96. Cortez-Pinto H; Machado MV. "The dark side of sports: using steroids may harm your liver.". (2011): http://europepmc.org/abstract/med/21281427.
    10.1111/j.1478-3231.2010.02445.x
  97. Cortez-Pinto H; Machado MV. "Osteopontin: a missing link between hedgehog signaling and fibrosis in nonalcoholic steatohepatitis.". (2011): http://europepmc.org/abstract/med/21274859.
    10.1002/hep.24118
  98. Borges M; Cortez-Pinto H; Costa J; Gouveia M; Vaz Carneiro A; dos Santos Pinheiro L; Cortez-Pinto, Helena; et al. "The burden of disease and the cost of illness attributable to alcohol drinking--results of a national study.". Alcoholism: Clinical and Experimental Research (2010): no-no. http://europepmc.org/abstract/med/20528821.
    10.1111/j.1530-0277.2010.01229.x
  99. Bellentani S; Cortez-Pinto H; Day C; Marchesini G; Ratziu V. "A position statement on NAFLD/NASH based on the EASL 2009 special conference.". (2010): http://europepmc.org/abstract/med/20494470.
    10.1016/j.jhep.2010.04.008
  100. Cortez-Pinto H; Machado MV; Oliveira AG. "Hepatic steatosis in patients coinfected with human immunodeficiency virus/hepatitis C virus: a meta-analysis of the risk factors.". (2010): http://europepmc.org/abstract/med/20578130.
    10.1002/hep.23619
  101. Jorge, Zulmira; Carvalho, Maria Raquel; Guerra, Anabela S; Alves, Natália; De Almeida, José Mendes; Fagundes, Maria João; Cortêz-Pinto, Helena; et al. "Malnutrition in morbid obesity.". (2010): https://www.actamedicaportuguesa.com/revista/index.php/amp/article/view/605.
    10.20344/amp.605
  102. Telles-Correia, Diogo; Cortez-Pinto, Helena; Barbosa, António; Mega, Inês; Monteiro, Estela; Barbosa A; Cortez-Pinto H; et al. "Quality of life following liver transplantation: a comparative study between Familial Amyloid Neuropathy and liver disease patients". BMC Gastroenterology 9 1 (2009): http://dx.doi.org/10.1186/1471-230x-9-54.
    10.1186/1471-230x-9-54
  103. Cortez-Pinto H; Machado MV. "Uncoupling proteins and non-alcoholic fatty liver disease.". (2009): http://europepmc.org/abstract/med/19328582.
    10.1016/j.jhep.2009.02.019
  104. Cortez-Pinto, Helena; Machado, Mariana V.. "Uncoupling proteins and non-alcoholic fatty liver disease". Journal of Hepatology 50 5 (2009): 857-860. http://dx.doi.org/10.1016/j.jhep.2009.02.019.
    10.1016/j.jhep.2009.02.019
  105. Almeida R; Camilo ME; Cortez-Pinto H; Gonçalves MS; Machado MV; Marques-Vidal P; Martins A. "Does the simultaneous tumor necrosis factor receptor 2, tumor necrosis factor promoter gene polymorphism represent a higher risk for alcoholic liver disease?". (2009): http://europepmc.org/abstract/med/19212208.
    10.1097/MEG.0b013e32831016e0
  106. Almeida MR; Camilo ME; Cortez-Pinto H; Machado MV; Martins A; Ravasco P. "Iron homeostasis and H63D mutations in alcoholics with and without liver disease.". (2009): http://europepmc.org/abstract/med/19115475.
    10.3748/wjg.15.106
  107. Cortez-Pinto H; Machado MV. "Insulin resistance and steatosis in chronic hepatitis C.". (2009): http://europepmc.org/abstract/med/19381127.
  108. Cortez-Pinto H; Machado M. "Are genes really important in alcoholic liver disease?". (2008): http://europepmc.org/abstract/med/18989150.
    10.1097/MEG.0b013e328304b6dd
  109. Aranha MM; Camilo ME; Cortez-Pinto H; Costa A; Rodrigues CM; da Silva IB; de Moura MC. "Bile acid levels are increased in the liver of patients with steatohepatitis.". (2008): http://europepmc.org/abstract/med/18467911.
    10.1097/MEG.0b013e3282f4710a
  110. Cortez-Pinto H; Machado M. "Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease.". (2008): http://europepmc.org/abstract/med/19072357.
    10.1586/17474124.2.2.217
  111. Cortez-Pinto, Helena; Machado, Mariana. "Impact of body weight, diet and lifestyle on nonalcoholic fatty liver disease". Expert Review of Gastroenterology & Hepatology 2 2 (2008): 217-231. http://dx.doi.org/10.1586/17474124.2.2.217.
    10.1586/17474124.2.2.217
  112. Cortez-Pinto H; Machado M. "Previous practice of high-intensity sports as a risk factor for non-alcoholic steatohepatitis.". (2008): http://europepmc.org/abstract/med/18290780.
    10.1111/j.1478-3231.2008.01663.x
  113. Baldeiras I; Camilo ME; Cortez-Pinto H; Jesus L; Machado MV; Marques-Vidal P; Oliveira CR; Proença T; Ravasco P. "Blood oxidative stress markers in non-alcoholic steatohepatitis and how it correlates with diet.". (2008): http://europepmc.org/abstract/med/18938777.
    10.1080/00365520701559003
  114. Cortez-Pinto H; Machado M. "Nash, insulin resistance and iron.". (2006): http://europepmc.org/abstract/med/17105580.
    10.1111/j.1478-3231.2006.01394.x
  115. Cortez-Pinto, H.; Jesus, L.; Barros, H.; Lopes, C.; Moura, M.C.; Camilo, M.E.. "How different is the dietary pattern in non-alcoholic steatohepatitis patients?". Clinical Nutrition 25 5 (2006): 816-823. http://dx.doi.org/10.1016/j.clnu.2006.01.027.
    10.1016/j.clnu.2006.01.027
  116. Cortez-Pinto H; Machado M; Marques-Vidal P. "Hepatic histology in obese patients undergoing bariatric surgery.". (2006): http://europepmc.org/abstract/med/16899321.
    10.1016/j.jhep.2006.06.013
  117. Cortez-Pinto H; Machado M. "Non-alcoholic steatohepatitis and metabolic syndrome.". (2006): http://europepmc.org/abstract/med/16912563.
    10.1097/01.mco.0000241677.40170.17
  118. Camilo ME; Castro RE; Cortez-Pinto H; Costa A; Moura MC; Ramalho RM; Rodrigues CM; Solá S. "Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis.". (2006): http://europepmc.org/abstract/med/16357615.
    10.1097/00042737-200601000-00005
  119. Cortez-Pinto, Helena; de Moura, Miguel Carneiro; Day, Christopher Paul; Cortez-Pinto H; Day CP; de Moura MC. "Non-alcoholic steatohepatitis: From cell biology to clinical practice". Journal of Hepatology 44 1 (2006): 197-208. http://dx.doi.org/10.1016/j.jhep.2005.09.002.
    10.1016/j.jhep.2005.09.002
  120. CORTEZ-PINTO, H.. "Concluding remarks: metabolic syndrome, liver and HCV". Alimentary Pharmacology and Therapeutics 22 s2 (2005): 83-85. http://dx.doi.org/10.1111/j.1365-2036.2005.02604.x.
    10.1111/j.1365-2036.2005.02604.x
  121. Camilo ME; Cortez-Pinto H; Gonçalves MS; Machado M; Marques-Vidal P; Martins A; Soren S; de Moura MC. "Are genetic polymorphisms of tumour necrosis factor alpha, interleukin-10, CD14 endotoxin receptor or manganese superoxide dismutase associated with alcoholic liver disease?". (2005): http://europepmc.org/abstract/med/16148556.
    10.1097/00042737-200510000-00014
  122. Cortez-Pinto, Helena; Ermelinda Camilo, Maria; Camilo ME; Cortez-Pinto H. "Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): diagnosis and clinical course". Best Practice & Research Clinical Gastroenterology 18 6 (2004): 1089-1104. http://dx.doi.org/10.1016/j.bpg.2004.06.021.
    10.1016/j.bpg.2004.06.021
  123. Baptista A; Camilo ME; Castro RE; Cortez-Pinto H; Moura MC; Ramalho RM; Ribeiro PS; Rodrigues CM; Solá S. "Hepatocyte apoptosis, expression of death receptors, and activation of NF-kappaB in the liver of nonalcoholic and alcoholic steatohepatitis patients.". (2004): http://europepmc.org/abstract/med/15330907.
    10.1111/j.1572-0241.2004.40009.x
  124. Cortez-Pinto H; Marques-Vidal P; Monteiro E. "Liver disease-related admissions in Portugal: clinical and demographic pattern.". (2004): http://europepmc.org/abstract/med/15316411.
    10.1097/00042737-200409000-00010
  125. Baptista A; Camilo ME; Cortez-Pinto H; De Moura MC. "Nonalcoholic steatohepatitis--a long-term follow-up study: comparison with alcoholic hepatitis in ambulatory and hospitalized patients.". (2003): http://europepmc.org/abstract/med/14627331.
    10.1023/A:1026152415917
  126. Alexandrino P; Alves MM; Camilo ME; Cortez-Pinto H; Gouveia-Oliveira A; Moura MC; Santos PM. "Lack of effect of colchicine in alcoholic cirrhosis: final results of a double blind randomized trial.". (2002): http://europepmc.org/abstract/med/11943949.
    10.1097/00042737-200204000-00007
Thesis / Dissertation
  1. Reis, Ana Catarina Ferrão. "A importância dos cuidados paliativos na doença hepática terminal". Master, 2021. http://hdl.handle.net/10451/51262.
  2. Henriques, Ana Carolina Freitas. "Colangite biliar primária : tratamento clássico e novas perspetivas". Master, 2018. http://hdl.handle.net/10451/41756.
  3. Serrano, Sílvia Isabel Serrasqueiro. "Esteato-hepatite não alcoólica (EHNA) : métodos não invasivos". Master, 2017. http://hdl.handle.net/10451/33504.
  4. Costa, Catarina Borges, 1989-. "Evolução do padrão alimentar a longo prazo após cirurgia bariátrica". Master, 2017. http://hdl.handle.net/10451/39308.
  5. Moutinho, Ana Carlota Feu Dias Ferreira. "Tuberculose peritoneal : um desafio diagnóstico". Master, 2016. http://hdl.handle.net/10451/25870.
  6. Aguiar, Maria Margarida Branco Antunes Baptista Queiroz; Aguiar, Maria Margarida Branco Antunes Baptista Queiroz, 1964-. "Nutrição parentérica em meio hospitalar: prescrição, produção e acompanhamento clínico (estudo observacional sobre o impacto do IMC e da ingestão calórica-proteica no resultado clínico)". Master, 2016. http://hdl.handle.net/10400.21/11425.
  7. Lopes, Mariana Martins Conceição da Silva, 1992. "Padrão nutricional de doentes cirróticos e de doentes com carcinoma hepatocelular". Master, 2016. http://hdl.handle.net/10451/32876.
  8. Boieiro, Inês Mónica, 1991-. "Estágio no Centro de Medicina de Reabilitação da Região Centro - Rovisco Pais : avaliação do estado nutricional e da capacidade funcional de doentes com diagnóstico clínico de AVC". Master, 2016. http://hdl.handle.net/10451/33349.
  9. Figueiredo, Patrícia Filipa Conde, 1992-. "Doença aguda do enxerto-versus-hospedeiro : a propósito de um caso clínico". Master, 2016. http://hdl.handle.net/10451/29332.
  10. Almeida, Leonor de Faro Viana Pereira de, 1988-. "Relatório de estágio em nutrição clínica : observação e atuação no apoio nutricional em diversos serviços hospitalares". Master, 2016. http://hdl.handle.net/10451/27284.
  11. Marques, Fernando Humberto Fernandes. "Tuberculose peritoneal em doente VIH positivo : caso clínico". Master, 2015. http://hdl.handle.net/10451/25273.
  12. Penedo, Cláudia Sofia Gastão, 1990-. "Estado nutricional dos doentes oncológicos seguidos numa consulta de dietética e nutrição : relatório de estágio efetuado no Serviço de Dietética e Nutrição do Hospital de Santa Maria, EPE, Centro Hospitalar Lisboa Norte". Master, 2015. http://hdl.handle.net/10451/23312.
  13. Coelho, Ana Raquel Mano, 1989-. "Relatório de estágio de nutrição em hematologia". Master, 2015. http://hdl.handle.net/10451/24043.
  14. Queirós, Ana Clara do Vale, 1991-. "Estágio no Serviço de Dietética e Nutrição e no Departamento de Neurologia no Hospital de Santa Maria, Centro Hospitalar Lisboa Norte". Master, 2015. http://hdl.handle.net/10451/23505.
  15. Bandeira, Adriana. "Eixo intestino fígado na doença hepática alcoólica : artigo de revisão". Master, 2015. http://hdl.handle.net/10451/24741.
  16. Penedo, Cláudia Sofia Gastão. "Estado nutricional dos doentes oncológicos seguidos numa consulta de dietética e nutrição". Master, 2015. http://hdl.handle.net/10400.21/13407.
  17. Duarte, Ana Luisa Marques. "Nutrição na fisiopatologia e tratamento do fígado gordo não-alcoólico". Master, 2014. http://hdl.handle.net/10451/23829.
  18. Silvestre, MP. "Regulatory interactions between the metabolic sensors SIRT1 and AMPK in modulating PPARa linked functions, in obesity-dependent type 2 diabetes mellitus". PhD, 2014. http://hdl.handle.net/10451/12209.
  19. Magalhães, Nuno Manuel Queiroz Pimenta de. "Body composition in non-alcoholic fatty liver disease patients". PhD, 2014. http://hdl.handle.net/10400.5/7450.
  20. Gago, Miguel Franco Morgadinho. "Fígado gordo não-alcoólico : uma entidade emergente com potencial oncogénico". Master, 2014. http://hdl.handle.net/10451/24409.
  21. Ribeiro, Liliana Neves, 1989-. "Determinantes do padrão dietético no risco de desenvolver esteatose hepática, na população portuguesa". Master, 2014. http://hdl.handle.net/10451/23492.

Other

Other output
  1. Tempo de reflexão. 2014. Cortez-Pinto,Helena. http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-81782014000300001.
  2. Permeabilidade intestinal em doentes com cirrose hepática: correlação com endotoxinémia e níveis circulantes de TNF a, IL-1, E IL-6. 2011. Mão de Ferro,Susana; Salazar,Maria; Machado,Mariana; Ramalho,Fernando; Cortez Pinto,Helena; Ferro,Susana Mão de; Pinto,Helena Cortez. http://scielo.pt/scielo.php?script=sci_arttext&pid=S0872-81782011000300013.
Activities

Oral presentation

Presentation title Event name
Host (Event location)
2021/11/19 Treatment of Wilson's disease patients Gastroweekend
2021/10/06 Impact of gender in liver disease UEG Week
United European Gastroenterology (Vienna, Austria)
2021/10/06 NASH: Novel Insights in pathophysiology UEG Week
United European Gastroenterology (Vienna, Austria)
2021/09/16 NAFLD: a public health threat? NAFLD EASL Summit
Home of Hepatology (Geneva, Switzerland)
2021/07/30 Tratamento da MASH Hepatologia do Mile´nio 2021 virtual
2021/07/30 Cirurgia bariátrica e NASH Hepatologia do Mile´nio 2021 virtual
2021/07/13 Tratamento atual da DHGNA - modificação do estilo de vida é suficiente XXX SEMANA DE FÍGADO DO RIO DE JANEIRO
2021/06/23 ole of bariatric surgery in NASH Postgraduate-course The international liver congress (EASL)
Home of Hepatology
2021/06/23 Unmasking NASH: the hepatic face of metabolic dysregulation. Overview and moderation The international liver congress (EASL)
Home of Hepatology
2021/06/16 Metabolic associated fatty liver disease (MAFLD) Final Conference Meeting
Project FOIE GRAS
2021/06/12 NAFLD: what the clinician needs to know Croatian Liver Week 2021
(Split, Croatia)
2021/05/29 Obesity and NAFLD World Digestive Health Day
The World Gastroenterology Organisation
2021/05/28 Metabolic associated fatty liver disease (MAFLD) Congresso APEF 2021
(Portugal)
2021/05/28 INTERVENÇÃO NUTRICIONAL NO FÍGADO GORDO NÃO ALCOÓLICO EM DOENTES INFETADOS PELO VIH Congresso Português de Hepatologia - 2ª Reunião Anual da APEF
Associação Portuguesa para o Estudo do Fígado (Portugal)
2021/04 Epidemiology of NAFLD The 4th Global NASH Congress
2021/03/03 New insights into NASH management International Conference on the Management of Liver Diseases
2020/11/27 Treatment of NASH Hepatologia do Milênio 2020
Associação de Gastroenterologia do Rio de Janeiro (Rio de Janeiro, Brazil)
2020/10/17 Benefícios e desvantagens da nomenclatura MAFLD XXIX Semana de Fígado do Rio de Janeiro 2020
A XXXI Semana de Fígado do Rio de Janeiro (Rio de Janeiro, Brazil)
2020/09/25 MANIFESTAÇÕES HEPATOBILIARES DA DII. Curso de formação em DII do GEDI
GEDII - Grupo de Estudos da Doença Inflamatória Intestinal (Porto)
2020/07/29 NASH: Treatment & New Trials Hepato Pernambuco 2020
Sociedade Brasileira de Hepatologia (Brazil)
2020/02/07 Estudos multicêntricos em Portugal. Que podemos/devemos investigar. Curso de formação da APEF
Associação Portuguesa para o Estudo do Fígado (Portugal)
2019/09/26 Implementation of public awareness and education in schools EASL NAFLD Summit
(Sevilha, Spain)
2019/09/05 Food, microbiota and nonalcoholic fatty liver disease, in Neurogastro 2019 biennal meeting of the European Society of Neurogastroenterology and Motility
2019/07/05 Food obesity and nonalcoholic fatty liver disease Spoleto Festival dei 2Mondi
2019 Global Perspectives On Nafld And Non-Alcoholic Steatohepatitis III ETN Foie Gras Summer School
2018 NAFLD/NASH – Do diagnóstico à terapêutica. XXXIII Reunião Anual NGHD
2018 Identification of NAFLD in Primary Care: Can Algorithms and Transient Elastography (TE) Predict Fibrosis? World Preclinical Congress
2018 Encefalopatia hepática – Como tratar 6º congresso SOS Hepatites
2018 Hepahealth: The burden of liver disease in Europe The international liver congress (EASL)
2018 Discussion: Why should be the EASL policy on alcohol in Europe The international liver congress (EASL)
2018 Policy recommendation arising out of HEPAHEALTH and next steps. The international liver congress (EASL)
2018 O que vai mudar? Novas guidelines da CBP Semana Digestiva
2018 Atualidade na abordagem da hepatite alcoólica aguda VII Simpósio de Hepatites Virais de Minas Gerais
2018 The changing priorities in chronic liver disease Clinics and Science in Hepatology

Supervision

Thesis Title
Role 		Degree Subject (Type)
Institution / Organization
2021 - 2021 "Impacto da sarcopénia na gravidade da cirrose hepática e do carcinoma hepatocelular"
Supervisor
 Nutrição Clínica (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
2018 - 2018 Non-alcoholic liver disease in HIV infected patients: prevalence, nutritional status and dietary habits
Supervisor
 Ciências e Tecnologias da Saúde (PhD)
Universidade de Lisboa Faculdade de Medicina, Portugal
2018 - 2018 Colangite Biliar Primária: Tratamento Clássico e Novas Perspetivas
Supervisor
 Medicina (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal
2017 - 2017 Esteato-hepatite não alcoólica - Métodos não invasivos.
Supervisor
 Medicina (Master)
Universidade de Lisboa Faculdade de Medicina, Portugal

Jury of academic degree

Topic
Role 		Candidate name (Type of degree)
Institution / Organization
2022/03/22 Desenvolvimento de um modelo experimental de doença hepática alcoólica em ratos Wistar: da lesão hepática à disbiose intestinal
(Thesis) Arguer
 Rutiane Ullmann Thoen (PhD)
Universidade Federal do Rio Grande do Sul, Brazil

Course / Discipline taught

Academic session Degree Subject (Type) Institution / Organization
2022/03 - 2022/07 Patologia II Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2021/09 - 2022/02 Patologia I Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2021/09 - 2022/02 Nutrição Artificial Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2021/03 - 2021/07 Patologia II Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2020/09 - 2021/02 Patologia I Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2020/02 - 2020/07 Patologia II Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
2019/09 - 2020/02 Patologia I Ciências da Nutrição (Licenciatura) Universidade de Lisboa Faculdade de Medicina, Portugal
Distinctions

Award

2020 Melhor Poster no Congresso Português de Hepatologia 2020
Associação Portuguesa para o Estudo do Fígado , Portugal
2003 Rising Star in Gastroenterology 2003 - Association of National European and Mediterranean Societies of Gastroenterology

Title

2021 Presidente da United European Gastroenterology (UEG)
United European Gastroenterology, Austria
2019 vice-presidente da United European Gastroenterology (UEG)
2016 Diretora do Internato Médico do Centro Hospitalar Lisboa Norte /HSM
Centro Hospitalar Universitário Lisboa Norte EPE, Portugal
2015 membro do “Governing Board” da European Association for the Study of the Liver (EASL), como conselheira para os assuntos da União Europeia (UE)
2015 membro da “Public Affair Committee (PAC) da UEG
2013 Presidente
Associação Portuguesa para o Estudo do Fígado , Portugal
2008 Fellow in Gastroenterology” pelo European Board of Gastroenterology